Compliance Information
ESMO Asia 2022 is organised by the European Society for Medical Oncology (based in Lugano, Switzerland). The congress is provided to international HCPs with a majority from Asia, in accordance with the international Industry Code of Practices and/or local approval in each country.
On-site
Participants fully registered to the congress, visitors wearing the visitors’ badge, exhibitors wearing the exhibitor badge and agencies wearing the Industry Satellite badge will have access to the satellite symposia sessions, at the discretion of the sponsoring company.
For ESMO Asia 2022, different badge coloured stripes will be used in order to allow identification of delegates as prescribers or nonprescribers. This decision has been taken to comply with prescription-only medicines promotional legislation, as far as applicable. (i) Delegates attending the Congress will be responsible when deciding which parts or areas of the congress they access, and (ii) By previously identifying their profile, pharmaceutical companies will be responsible when deciding how they engage or interact with participants, according to applicable laws and Codes of Practice.
Online
Satellite symposia sessions will be accessible for all registered delegates, however companies may add a disclaimer on top of their Satellite Symposium Virtual Space (see ESMO Asia 2022 Industry Guidelines, paragraph 5.2).